Function, cognition, and quality of life among older adults with lung cancer who live alone: A prospective cohort study
- PMID: 39288505
- PMCID: PMC12312441
- DOI: 10.1016/j.jgo.2024.102068
Function, cognition, and quality of life among older adults with lung cancer who live alone: A prospective cohort study
Abstract
Introduction: Among older adults without cancer, living alone is associated with poor health outcomes. However, among older adults with non-small cell lung cancer (NSCLC) who live alone, data on function, cognition, and quality of life (QOL) during systemic treatment remain limited.
Materials and methods: We enrolled adults aged ≥65 with advanced NSCLC starting a new chemotherapy, immunotherapy, and/or targeted therapy regimen with non-curative intent. Patients completed geriatric assessments including instrumental activities of daily living (IADL), Montreal Cognitive Assessment, and QOL pretreatment and at 1, 2, 4, and 6 months, or until treatment discontinuation, whichever occurred earlier. We categorized change in IADL, cognition, and QOL as stable/improved, declined with recovery, or declined without recovery using clinically meaningful definitions of change. We used multinomial logistic regression to compare change between patients who lived alone versus with others.
Results: Among 149 patients, median age was 73; 21% lived alone. Pretreatment IADL, cognition, and QOL scores were similar between older adults who lived alone versus with others. During NSCLC treatment, older adults who lived alone had similar trajectories of function (52% functional decline vs 38%), cognition (43% cognitive decline vs 50%), and QOL (45% QOL decline vs 44%) compared with those who lived with others. In unadjusted analyses, patients who lived alone were more likely to develop functional decline with recovery (reference category: stable/improved function) than those who lived with others (relative risk ratio 4.07, 95% CI 1.14-14.6, p = 0.03). However, this association was not observed after adjusting for age, race, prior NSCLC treatment, current treatment group, and pretreatment geriatric assessment differences. There were no differences in cognitive or QOL trajectories in unadjusted or adjusted analyses.
Discussion: Approximately half of older adults with advanced NSCLC who lived alone were able to maintain their function, cognition, and QOL during NSCLC treatment, which was similar to older adults who lived with others. Many older adults with advanced NSCLC who live alone can receive systemic treatment with individualized supportive care.
Keywords: Cognition; Function; Instrumental activities of daily living; Lung cancer; Older adults; Quality of life.
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest SS reported conflicts of interest outside the submitted work (consultant/advisory to Oncohost). AIV reported conflicts of interest outside the submitted work (consultant/advisory to Merus and AstraZeneca). LCS has received research funding from AstraZeneca awarded directly to her institution. MLW reported conflicts of interest outside of the submitted work (royalties from UpToDate; immediate family member is an employee of Genentech with stock ownership). The remaining authors have no conflicts to report.
Figures
References
-
- US Census Bureau. Historical Living Arrangements of Adults. Published 2022. Accessed February 27, 2023. https://www.census.gov/data/tables/time-series/demo/families/adults.html
Publication types
MeSH terms
Grants and funding
- KL2 TR001870/TR/NCATS NIH HHS/United States
- K24 AG068312/AG/NIA NIH HHS/United States
- K76 AG064431/AG/NIA NIH HHS/United States
- R03 AG056439/AG/NIA NIH HHS/United States
- R03 AG064374/AG/NIA NIH HHS/United States
- P30 CA082103/CA/NCI NIH HHS/United States
- P30 AG015272/AG/NIA NIH HHS/United States
- P30 AG028716/AG/NIA NIH HHS/United States
- K76 AG074923/AG/NIA NIH HHS/United States
- K76 AG064394/AG/NIA NIH HHS/United States
- P30 AG044281/AG/NIA NIH HHS/United States
- K08 CA234225/CA/NCI NIH HHS/United States
- P30 CA016058/CA/NCI NIH HHS/United States
- K76 AG074926/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
